Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-03-30
1989-02-21
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514252, 514255, 544360, 544369, 544373, 544385, A61K 31495, C07D40114, C07D41714
Patent
active
048065382
ABSTRACT:
The invention relates to a PAF-antagonist pharmaceutical composition comprising a compound of the formula: ##STR1## wherein R.sup.1 is pyridyl(lower)alkyl or thiazolyl(lower)alkyl,
REFERENCES:
patent: 3976773 (1976-08-01), Curran
patent: 4038429 (1977-07-01), Smith
patent: 4111925 (1978-09-01), Bachman
patent: 4289707 (1981-09-01), Caldwell et al.
patent: 4289759 (1981-09-01), Hearner et al.
patent: 4554102 (1985-11-01), Dorf et al.
patent: 4569793 (1986-02-01), Dorf et al.
patent: 4611076 (1986-09-01), Dorf et al.
patent: 4694081 (1987-09-01), Miller et al.
Kanmera et al, CA95-7743q.
Kanmera et al, CA93-221027m.
Hashimoto et al., CA93-215972c.
Chemical Abstracts, vol. 100, No. 29, 1984, p. 603, Col. 2, Abstract No. 209873q.
Chemical Abstracts, vol. 86, No. 34, 1977, p. 453, Col. 1, Abstract No. 16936w.
Chemical Abstracts, vol. 96, No. 34, 1982, Col. 2, Abstract No. 218218f.
Die Pharmazie., vol. 32, No. 1, Jan. 1977, pp. 1-16, Berlin, Johne et al: Naturstoffe mit Diketopiperazinstruktur.
Chemical Abstracts, vol. 96, No. 25, (1982) 218218.
Chemical Abstracts, vol. 86, No. 3 (1977), 16936.
Hashimoto Masashi
Hemmi Keiji
Miyazaki Yoshio
Nakaguti Osamu
Shimazaki Norihiko
Daus Donald G.
Fujisawa Pharmaceutical Co. Ltd.
Shen Cecilia
LandOfFree
Piperazine compound as PAF-antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine compound as PAF-antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine compound as PAF-antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1522397